South Africa’s Pharmacist-Initiated Management of ART (PIMART) will potentially pave the way for other countries in helping the under reached and under-served groups and communities in gaining access to their HIV medicines, as PIMART seeks to improve these links to HIV treatment and prevention therapy among these communities and the way they obtain their medication. […]
Read MoreAn online survey in the US has found that although gay and bisexual men who used PrEP(Pre Exposure Prophylaxis) had significantly more condomless sex with non-primary partners than men who didn’t use PrEP, they were less likely to be anxious. A relationship seen in previous studies between higher rates of condomless sex and more anxiety did not […]
Read Moremedworx update … The WHO has recommended pre-exposure prophylaxis, or PrEP, as an additional HIV prevention choice for people with a high risk of being infected. Truvada has been licensed in South Africa. For the first time university and college students will be able to access HIV prevention medication called Truvada. This was announced on […]
Read Moremedworx update … Researchers have developed a once-a-week pill to prevent HIV. The drug will take years before it is available, because it has to go through lengthy trials. This would be a welcome alternative to the pre-exposure prophylaxis pills available in most countries including Kenya, which must be swallowed daily. In May last […]
Read MoreBy Anne Harding October 05, 2016 NEW YORK (Reuters Health) – Gentian violet (GV) is as effective as nystatin for treating oral candidiasis (OC) in AIDS patients, at a fraction of the cost per treatment, according to new findings. “It was as effective, it was well tolerated, and it was much less expensive,” Dr. Robert Salata of […]
Read Moremedworx update … A clinical study funded by the National Institutes of Health has found that young, single black women in South Africa adhered to a daily pill regimen to prevent HIV infection — an HIV prevention strategy known as pre-exposure prophylaxis, or PrEP. This finding is the first strong indication that this population […]
Read MoreExperts around the world believe we’ve got what it takes to end the Aids epidemic by 2030. Big scientific breakthroughs and lessons that have been learned over the years are the backbone of this confidence. But “ending” Aids doesn’t mean there will be no new HIV infections. Rather, it suggests that the Aids epidemic can […]
Read MorePrivate-sector Re-possession of Ownership in the Practice of Medicine COPPA for PreP Private Medical Practitioner Initiative in providing Fee-for-Service Access to affordable Pre-HIV Exposure Prophylaxis (PreP) COPPA PreP Initiative in South Africa Fee -for-Service Doctor-driven Initiative in Measurable Pre -Exposure Prophylaxis against HIV infection and re-infection in South Africa A Private Sector Professional Coalition in […]
Read MoreThe US Food and Drug Administration (FDA) has approved dronabinol oral solution (Syndros, Insys Therapeutics, Inc) for the treatment of anorexia associated with weight loss in patients with AIDS and for nausea and vomiting associated with cancer chemotherapy in patients who fail to respond adequately to conventional antiemetic treatments, according to a company news release. […]
Read MoreSouth Africa has become one of the world’s first countries to begin rolling out pre-exposure prophylaxis as well as ‘test and treat’ to sex work...
read more